Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Background: One severe complication following solid organ transplantation is antibody and/or cell mediated rejection of the graft. Early detection of rejection is therefore of paramount importance to improve outcome of solid organ
transplantation.
The present study was conducted to determine the analytical performance of the Devyser kit designed for sensitive detection of
donor-derived cell-free DNA (dd-cfDNA) following kidney transplantation.
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...
Read More
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
Read More